High performance ozone based advanced oxidation processes catalyzed with novel argon plasma treated iron oxyhydroxide hydrate for phenazopyridine degradation

TiO2/graphene composite nanofibers for efficient photocatalytic degradation of pharmaceutical compounds: Rifampin, Phenazopyridine, Azathioprine

Pharmaceutical wastewater treatment is an essential component of environmental protection and sustainable development. In this study, our aim was to investigate the morphology, characterization, and effectiveness of TiO2/graphene composite nanofiber photocatalysts in the treatment of pharmaceutical wastewater containing three different pharmaceutical groups, such as an antibiotic (rifampin), painkiller (phenazopyridine), and immunosuppressant (azathioprine). Various parameters such as pH, salt concentration, and initial pharmaceutical compound concentration were optimized to achieve maximum degradation kinetics and efficiency. The optimum conditions were determined to be 1.5% graphene content, 30 ppm initial concentration of pharmaceutical compound, pH=5, and a 0.5 g/L photocatalyst dose. The presence of salt slightly decreased the degradation kinetics, but it did not significantly affect the performance of the TiO2/graphene composite nanofibers photocatalyst. At optimum condition, TiO2/1.5% graphene composite nanofibers degraded 50% of phenazopyridine, 86.89% of rifampin, and completely azathioprine. Comparing with phenazopyridine, N heteroatom-rich molecule of azathioprine and hydroxyl-rich molecule of rifampin lead to being susceptible to photocatalytic degradation. The reuse of the photocatalyst in multiple cycles showed consistent performance, indicating its potential for practical and economic applications.

High-performance NiO@Fe3O4 magnetic core-shell nanocomposite for catalytic ozonation degradation of pharmaceutical pollution

Pharmaceuticals that are present in superficial waters and wastewater are becoming an ecological concern. Therefore, it is necessary to provide high-performance methods to limit the harmful ecological effects of these materials to achieve a sustainable environment. In this research, NiO@Fe3O4 nanocomposite was prepared by the co-precipitation method and utilized in the catalytic ozonation process for the degradation of 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid (ciprofloxacin antibiotic), for the first time. The influencing parameters in the degradation process were analyzed and optimized via response surface methodology (RSM). The optimal ciprofloxacin removal efficiency (100%) was found at pH = 6.5, using 7.5 mg of the NiO@Fe3O4 nanocatalyst and 0.2 g L-1 h-1 ozone (O3) flow, applied over 20 min. Results showed a significant synergistic effect in the analyzed system, which makes the proposed catalytic ozonation process more efficient than using the catalyst and ozone separately. Also, based on the kinetic analysis data, the catalytic ozonation process followed the pseudo-first-order model. In addition, the nanocatalyst showed high recyclability and stability (88.37%) after five consecutive catalytic ozonation process cycles. In conclusion, the NiO@Fe3O4 nanocatalyst/O3 system can be effectively used for the treatment of pharmaceutical contaminants.

Ni-based catalysts used in heterogeneous catalytic ozonation for organic pollutant degradation: a minireview

Among various advanced oxidation processes for wastewater treatment, heterogeneous catalytic ozonation (HCO) has a growing interest in pollutant degradation, e.g., pesticides, pharmaceuticals, cresols, detergents, polymers, dyes, and others. Direct oxidation with ozone can occur by this route or indirectly, generating reactive oxygen species through the catalytic activation of the ozone molecule. Then, many catalytic materials were evaluated, such as unsupported and supported oxides, activated carbon, nanocarbons, carbon nitride, and mesoporous materials. This review focuses on the properties and performance of Ni-based catalysts (NiO, supported NiO, Ni ferrites, and M-Ni bimetallic), emphasizing the reaction mechanisms and the importance of the reactive oxygen species in removing toxic organic compounds.

Non-thermal plasma elicits ferrous chloride-catalyzed DMPO-OH

Non-thermal plasma (NTP) induces the generation of reactive oxygen species (ROS) and reactive nitrogen species, such as hydroxyl radicals (^•OH), hydrogen peroxide (H₂O₂), singlet oxygen, superoxide, ozone, and nitric oxide, at near-physiological temperatures. These molecules promote blood coagulation, wound healing, disinfection, and selective cancer cell death. Based on these evidences, clinical trials of NTP have been conducted for treating chronic wounds and head and neck cancers. Although clinical applications have progressed, the stoichiometric quantification of NTP-induced ROS remains unclear in the liquid phase in the presence of FeCl₂ or FeCl₃ in combination with biocompatible reducing agents, which may modulate the final biological effects of NTP. In this study, we employed electron paramagnetic resonance spectroscopy to quantify ROS using spin-trapping probe, 5,5-dimethyl-1-pyrroline-N-oxide (DMPO) and H₂O₂, using luminescent probe in the presence of FeCl₂ or FeCl₃. NTP-induced DMPO-OH levels were elevated 10-100 µM FeCl₂ or 500 and 1000 µM FeCl₃. NTP-induced DMPO-OH with 10 µM FeCl₂ or FeCl₃ was significantly scavenged by ascorbate, α-tocopherol, dithiothreitol, reduced glutathione, or oxidized glutathione, whereas dehydroascorbate was ineffective in 2 mM DMPO. NTP-induced H₂O₂ was significantly degraded by 100 µM FeCl₂ and FeCl₃ in an iron-dependent manner. Meanwhile, decomposition of H₂O₂ by catalase decayed DMPO-OH efficiently in the presence of iron, indicating iron causes DMPO-OH production and degradation simultaneously. These results suggest that NTP-induced DMPO-OH is generated by the H₂O₂-consuming, iron-dependent Fenton reaction and ferryl intermediates. The potential iron-mediated ROS production by NTP is also discussed to clarify the interaction between NTP-induced ROS and biomolecules.

Soft synthesis and characterization of goethite-based nanocomposites as promising cyclooctene oxidation catalysts

Goethite based nanocomposites with a different composition such as 6FeO(OH)·MnO(OH)·0.5H₂O (Mn-composite), xFeO(OH)·M(OH)₂·yH₂O (Co-composite (M: Co, x = 12, y = 3), Ni-composite (M: Ni, x = 7, y = 2)) and xFeO(OH)·MO·yH₂O (Cu-composite (M: Cu, x = 5.5, y = 3), Zn-composite (M: Zn, x = 6, y = 1.5)) have been prepared by a soft chemical synthesis consisting in acetate hydrolysis. The data provided by Fourier transform infrared (FTIR), ultraviolet-visible-near infrared (UV-Vis-NIR), electron paramagnetic resonance (EPR) and Mössbauer spectra account for a slight modification of all composites' physicochemical properties compared to the starting material. Powder X-ray diffraction and transmission electron microscopy (TEM) investigations revealed the secondary phase nature and presence along with that of goethite. The TEM data are also consistent with a nano rod-like morphology with a 5–10 nm width and an average length of 40 nm. The catalytic oxidation of cyclooctene with O₂ using isobutyraldehyde as reductant and acetonitrile as a solvent was performed in batch conditions for 5 h at room temperature. The selectivity for the epoxide was higher than 99% for all tested solids. The conversion of cyclooctene decreased from 55% to 4% following the same order of variance as the base/acid sites ratio: Mn-composite > Fe-composite > Co-composite > Ni-composite > Zn-composite > Cu-composite. The 6FeO(OH)·MnO(OH)·0.5H₂O (Mn-composite) exhibited the most promising catalytic activity in cyclooctene oxidation, which can be correlated with the redox ability of Mn(iii) combined with the increased base character of this solid. The catalytic activity of this sample decreases by 10% after several successive reaction cycles.

Goethite based nanocomposites with different compositions (6FeO(OH)·MnO(OH)·0.5H₂O, xFeO(OH)·M(OH)₂·yH₂O or xFeO(OH)·MO·yH₂O where M = Co, Ni, Cu or Zn) have been prepared by a soft chemical synthesis via acetate hydrolysis.